When science is not enough: a framework towards more customer-focused drug development
Advances in Therapy
Health Communications, Inc.
MetadataShow full item record
Oraiopoulos, N., & Dunlop, W. (2017). When science is not enough: a framework towards more customer-focused drug development. Advances in Therapy, 34 (7), 1572-1583. https://doi.org/10.1007/s12325-017-0567-y
The purpose of this study was to identify the key barriers to a customer-focused drug development process and develop a comprehensive framework to overcome them. METHODS: The paper draws on existing literature, both academic and practitioner, across a range of disciplines (innovation management, marketing, organizational behavior, behavioral economics, health economics, industry reports). On the basis of this extensive review, a conceptual framework is developed that offers concrete suggestions on how organizations can overcome the barriers and enable a more customer-focused development process. RESULTS: The barriers to collaboration are organized into three distinct categories (economic, behavioral, organizational), and within each category, a one-to-one mapping between barriers and solutions is developed. CONCLUSION: The framework is specifically designed with the objective of offering actionable and practical advice to executives who face these challenges in their organizations. The paper provides a unique theoretical contribution by synthesizing findings from several academic disciplines with concrete examples from the pharmaceutical industry. FUNDING: Mundipharma International Limited.
Business, Customer-focused development, Drug development, Finance, Health economics, Market access, Patient access, Pharmaceuticals, R&D management, Value frameworks
Mundipharma International Limited
External DOI: https://doi.org/10.1007/s12325-017-0567-y
This record's URL: https://www.repository.cam.ac.uk/handle/1810/269679